Table 2. Expression of CDO1 in multple types of human cancer.
aTissue type | Down | Up | bn/c | Total cases |
Colon | 5 | 1 | 4 | 10 |
Stomach | 6 | 1 | 3 | 10 |
Rectum | 4 | 0 | 6 | 10 |
Small Intestine | 3 | 1 | 3 | 7 |
Pancreas | 6 | 0 | 1 | 7 |
Liver | cn/d | cn/d | 3 | |
Thyroid Gland | 8 | 2 | 0 | 10 |
Skin | 9 | 1 | 0 | 10 |
Kidney | 8 | 0 | 2 | 10 |
Bladder | 4 | 1 | 0 | 5 |
Trachea | 1 | 0 | 2 | 3 |
Lung | 10 | 0 | 0 | 10 |
Breast | 9 | 0 | 1 | 10 |
Ovary | 8 | 0 | 2 | 10 |
Uterus | 9 | 0 | 1 | 10 |
Cervix | 8 | 0 | 2 | 10 |
Vulva | 4 | 0 | 1 | 5 |
Testis | 4 | 2 | 4 | 10 |
Prostate | 1 | 1 | 2 | 4 |
Cancer profiling II was performed to compare CDO1 expression between tumor and corresponding normal cases of multiple tissue types.
n/c, no change;
n/d, not determined.
Note, CDO1 expression in normal and tumor liver could not be compared due to abundant expression of CDO1 in the tissue.